doi: 10.1016/j.neuint.2012.11.017
Pnb-0408
Allergic or hypersensitivity reactions (rare) May occur in response to peptide compounds or formulation preservatives
Overall funding was approximately $60 million in SBIR funding (over 3 fiscal years), while matching stakeholder funding was about $180 million
14 While these findings highlight the therapeutic potential of dual GLP-1/glucagon receptor agonism in adults, evidence in adolescent populations is currently lacking
However, the majority of differentially expressed proteins involved in transcription (48) and translation (30) were repressed after SARS-CoV-2 infection, including the highly abundant proteins DIDO1, SUB1, FUBP1, TCEA1, BOP1, RPS24, and RPS15 (Supplementary Table 3 and Figure 5A)